What Are the Risks of Fallopian Tube Removal?

Removing your fallopian tubes (a procedure called a salpingectomy) is a highly effective way to reduce your risk of ovarian cancer, as many of these cancers actually begin in the tubes ^[1][2]. If you are considering this procedure—whether on its own, during a hysterectomy, or instead of traditional “tube tying” (tubal ligation)—it is natural to wonder about the risks. The reassuring news is that salpingectomy is considered a safe procedure with complication rates very similar to other routine gynecological surgeries ^[3][4]. When performed carefully to preserve the blood supply to your ovaries, current research shows that removing the tubes does not typically cause early menopause or significantly reduce your ovarian hormone production ^[5][6].

Important Considerations for Future Fertility

If you are choosing a salpingectomy instead of a standard tubal ligation for permanent birth control, it is crucial to understand that this procedure is completely irreversible. While some traditional tubal ligations can occasionally be surgically reversed to allow for natural pregnancy, a salpingectomy cannot. Once the tubes are removed, the only way to achieve pregnancy is through In Vitro Fertilization (IVF) ^[7].

However, a major medical benefit is that a full salpingectomy virtually eliminates the risk of an ectopic pregnancy (a life-threatening condition where a fertilized egg implants in the tube), which remains a small risk with standard tubal ligation ^[8].

Immediate Surgical Risks

Like any surgery, removing the fallopian tubes carries standard baseline risks, such as bleeding, infection, or adverse reactions to anesthesia. If performed as a standalone procedure, it will require general anesthesia and small incisions in your abdomen (laparoscopy), which carry a minor risk of port-site infection or scarring.

However, when a salpingectomy is added to another planned surgery—such as a hysterectomy or a cesarean section (an opportunistic salpingectomy)—it does not significantly increase your risk of major complications, nor does it extend the time you need to spend in the hospital ^[3][7].

• Operative time: Removing the entire tube may add a few extra minutes to the surgery compared to a standard tubal ligation, but this increase is minimal (often two minutes or less) ^[9][10].
• Recovery and pain: Your return to normal activities will look very similar to someone who did not have their tubes completely removed ^[7][11]. Some studies suggest you might have a slightly higher likelihood of needing pain medication in the first two weeks of recovery, but the overall healing process is comparable ^[12].
• Surgical injury: As with any pelvic surgery, there is a very rare risk of accidental damage to nearby pelvic organs, such as the bowel, bladder, or ureters ^[13][14].
• Adhesions: If you have scar tissue (adhesions) from past surgeries or conditions like endometriosis, the surgery can be more complex ^[15]. Sometimes, a surgeon may intentionally leave a small piece of the tube behind if dense scar tissue makes complete removal too dangerous ^[15].
• Insurance coverage: If you are having your tubes removed primarily for birth control, it is worth checking with your insurance provider, as coverage and out-of-pocket costs can sometimes vary between a standard tubal ligation and a complete salpingectomy.

Long-Term Risks to Ovarian Function and Menopause

A primary concern for many patients is whether removing the fallopian tubes will trigger early menopause. The ovaries and the fallopian tubes sit very close to each other and share a delicate network of blood vessels. If the blood supply to the ovaries is damaged during the removal of the tubes, it could theoretically lower your ovarian reserve (the health and supply of your eggs) and hasten menopause ^[6][16].

Fortunately, extensive clinical data shows that when surgeons use careful techniques to separate the tubes from the ovaries, salpingectomy generally does not negatively impact short-term ovarian function ^[17].

• Hormone levels: Tests measuring ovarian reserve (such as AMH and FSH levels) typically show no significant drop following a salpingectomy compared to other sterilization methods ^[5][18].
• Menopause timing: Long-term follow-up studies indicate no signs of an earlier onset of natural menopause in women who have had their tubes removed ^[19][2].
• Surgical technique matters: To protect the ovarian blood supply, surgeons must carefully cut the tissue (the mesosalpinx) connecting the tube and ovary. Research suggests that using certain advanced surgical tools, like ultrasonic shears, may be safer for preserving blood flow than traditional heat-based cautery ^[20]. While short-term data is very reassuring, medical researchers continue to track patients to ensure there are no subtle, long-term impacts on ovarian health ^[21].

Rare Complications: Hydrosalpinx

To get the maximum cancer-prevention benefit, the entire fallopian tube must be removed, especially the fringed ends (the fimbriae) that brush against the ovaries. If a portion of the tube cannot be safely removed due to dense scar tissue, or if a small remnant is unintentionally left behind, it can occasionally fill with fluid and swell ^[22].

This rare condition is known as a hydrosalpinx. While immediate post-operative soreness is a perfectly normal part of healing, a hydrosalpinx might cause new or persistent pelvic pain weeks or months after you have recovered. This kind of delayed or worsening pain should prompt you to contact your doctor, as it might require another procedure to correct ^[22].

Considerations for High-Risk Patients

For patients with a high genetic risk of ovarian cancer (such as those with a BRCA1 or BRCA2 mutation), the standard recommendation has historically been to remove both the tubes and the ovaries (a risk-reducing salpingo-oophorectomy). While this dramatically lowers cancer risk, removing the ovaries throws premenopausal women into immediate surgical menopause. This can cause severe hot flashes, vaginal dryness, sexual dysfunction, and long-term bone and heart health risks ^[23][24].

Clinical trials are currently exploring a two-step approach: removing just the fallopian tubes first to lower cancer risk, and delaying the removal of the ovaries until the patient is closer to the age of natural menopause (often targeted around age 40 to 45 for BRCA1, and 45 to 50 for BRCA2, depending on standard clinical guidelines) ^[25][26].

Early results from these trials show this staged strategy preserves ovarian function and significantly improves menopause-related quality of life compared to removing the ovaries early ^[25]. However, because the exact cancer risk reduction of this two-step method is still being studied, it is usually only recommended as part of a clinical trial or after extensive genetic and surgical counseling ^[26][27].